Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology

Veterinary Therapeutics

Volumn 6, Issue 2, 2005, Pages 113-121

  Godinho, Kevin S ^a   Keane, Sue G ^b   Nanjiani, Ian A ^a   Benchaoui, Hafid A ^a   Sunderland, Simon J ^a   Jones, M Anne ^b   Weatherley, Andrew J ^a   Gootz, Thomas D ^c   Rowan, Tim G ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b Leeds Veterinary Laboratories   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DISACCHARIDE; HETEROCYCLIC COMPOUND; TULATHROMYCIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CATTLE; CATTLE DISEASE; DRUG EFFECT; EUROPE; GRAM NEGATIVE BACTERIUM; HISTOPHILUS SOMNI; IN VITRO STUDY; ISOLATION AND PURIFICATION; MANNHEIMIA HAEMOLYTICA; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PASTEURELLA MULTOCIDA; SWINE; SWINE DISEASE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; DISACCHARIDES; EUROPE; GRAM-NEGATIVE BACTERIA; HAEMOPHILUS SOMNUS; HETEROCYCLIC COMPOUNDS; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; PASTEURELLA MULTOCIDA; PASTEURELLOSIS, PNEUMONIC; SWINE; SWINE DISEASES;

ACTINOBACILLUS PLEUROPNEUMONIAE; BOS TAURUS; BOVINAE; HISTOPHILUS SOMNI; MANNHEIMIA HAEMOLYTICA; PASTEURELLA MULTOCIDA; SUIDAE; SUS SCROFA;

EID: 24044453272     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Letavic MA, Bronk BS, Bertsche CD, et al: Synthesis and activity of a novel class of tribasic macrocyclic antibiotics: The triamilides. Bioorg Med Chem Lett 12:2771-2774, 2002.
2. Nowakowski MA, Inskeep P, Risk J, et al: Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 5:60-74, 2004.
3. Norcia LJ, Silvia AM, Santoro SL, et al: In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens. J Antibiot (Tokyo) 57:280-288, 2004.
4. Nowakowski M, Linhares M, Bunger A, et al: Pharmacokinetic profiles of some triamilides, a new class of macrolide, in mice and cattle [abstract A-22]. Proc 9th International Congress of the European Association for Veterinary Pharmacology and Therapeutics. J Vet Pharmacol Ther 26:100, 2003.
5. Benchaoui HA, Nowakowski MA, Sherington J, et al: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Ther 27:203-210, 2004.
6. Kamicker BJ, Mann DD, Hassfurther RL, et al: Therapeutic and metaphylactic activity of azalides and triamilides in the treatment of naturally occurring bovine respiratory disease [abstract D-26]. Proc 9th International Congress of the European Association for Veterinary Pharmacology and Therapeutics. J Vet Pharmacol Ther 26:233-234, 2003.
7. Kamicker BJ, Mann DD, Hassfurther RL, et al: Therapeutic and prophylactic activity of azalides and triamilides in the treatment of bovine respiratory disease [abstract D-27]. Proc 9th International Congress of the European Association for Veterinary Pharmacology and Therapeutics. J Vet Pharmacol Ther 26:234, 2003.
8. The European Union Committee for Veterinary Medicinal Products: EU Note for Guidance: Good Clinical Practice for the Conduct of Clinical Trials on Veterinary Medicinal Products in the European Union. Brussels, Belgium, FEDESA, July 1994.
9. National Committee for Clinical Laboratory Standards (NCCLS; now Clinical and Laboratory Standards Institute [CLSI]): Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals [approved standard]. Doc. No. M31-A; Vol. 19, No. 11, June 1999.
10. Landén A, Horn AF, Rantzien M, Franklin A: MIC values for porcine Actinobacillus pleuropneumoniae isolated in Sweden. Proc 16th Int Pig Vet Soc Congr: 142, 2000.
11. Pfaller MA, Jones RN, Walter DH: The Quality Control Study Group: Proposed quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using the veterinary antimicrobial agent tiamulin. Diagn Microbiol Infect Dis 40:67-70, 2001.
12. 2 and serum) on MIC values of tulathromycin against Haemophilus somnus [abstract 532]. Proc 23rd World Buiatrics Congr: 70-71, 2004.
13. 2. J Antimicrobial Chemother 41:387-389, 1998.
14. Barry AL, Fuchs PC: Influence of the test medium on azithromycin and erythromycin regression statistics. Eur J Clin Microbiol Infect Dis 10:846-849, 1991.
15. Carbon C: Pharmacodynamics of macrolides, azalides and streptogramins: Effect on extracellular pathogens. Clin Infect Dis 27:28-32, 1998.
16. Aarestrup FM, Jensen NE: Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests. Vet Microbiol 64:299-305, 1999.
17. Barigazzi G, Raffo A, Guarini CPB: Sensitivity to tilmicosin (Elanco AH) of recent porcine lung isolates and correlation between minimal inhibitory concentration (MIC) and Kirby-Bauer test. Proc 16th Int Pig Vet Soc Congr: 138, 2000.
18. Pruul H, McDonald PJ: Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. Antimicrob Agents Chemother 36:10-16, 1992.